DE60042196D1 - In der e1b-region deletierte, adenovirale shuttle-vektoren - Google Patents

In der e1b-region deletierte, adenovirale shuttle-vektoren

Info

Publication number
DE60042196D1
DE60042196D1 DE60042196T DE60042196T DE60042196D1 DE 60042196 D1 DE60042196 D1 DE 60042196D1 DE 60042196 T DE60042196 T DE 60042196T DE 60042196 T DE60042196 T DE 60042196T DE 60042196 D1 DE60042196 D1 DE 60042196D1
Authority
DE
Germany
Prior art keywords
region
deleted
shuttle vectors
gene
adenoviral shuttle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60042196T
Other languages
English (en)
Inventor
Terry Hermiston
Julie Nye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onyx Pharmaceuticals Inc
Original Assignee
Onyx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Pharmaceuticals Inc filed Critical Onyx Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60042196D1 publication Critical patent/DE60042196D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
DE60042196T 1999-01-28 2000-01-26 In der e1b-region deletierte, adenovirale shuttle-vektoren Expired - Lifetime DE60042196D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11781499P 1999-01-28 1999-01-28
PCT/US2000/002029 WO2000044922A1 (en) 1999-01-28 2000-01-26 E1b-deleted adenoviral shuttle vectors

Publications (1)

Publication Number Publication Date
DE60042196D1 true DE60042196D1 (de) 2009-06-25

Family

ID=22374975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60042196T Expired - Lifetime DE60042196D1 (de) 1999-01-28 2000-01-26 In der e1b-region deletierte, adenovirale shuttle-vektoren

Country Status (10)

Country Link
EP (1) EP1135514B1 (de)
AT (1) ATE431421T1 (de)
AU (1) AU772544B2 (de)
CA (1) CA2360355A1 (de)
CY (1) CY1109288T1 (de)
DE (1) DE60042196D1 (de)
DK (1) DK1135514T3 (de)
ES (1) ES2325303T3 (de)
PT (1) PT1135514E (de)
WO (1) WO2000044922A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
US20030219410A1 (en) * 2002-02-01 2003-11-27 Transgene S.A. Adenoviral vectors for modulating the cellular activities associated to PODs
HUE046565T2 (hu) * 2009-03-02 2020-03-30 Univ California Tumorszelektív adenovírus E1A és E1B mutánsok

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670488A (en) * 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5981275A (en) * 1997-04-14 1999-11-09 Genzyme Corporation Transgene expression system for increased persistence

Also Published As

Publication number Publication date
CY1109288T1 (el) 2014-07-02
DK1135514T3 (da) 2009-09-07
AU2861300A (en) 2000-08-18
EP1135514B1 (de) 2009-05-13
ES2325303T3 (es) 2009-09-01
PT1135514E (pt) 2009-07-20
EP1135514A1 (de) 2001-09-26
CA2360355A1 (en) 2000-08-03
AU772544B2 (en) 2004-04-29
WO2000044922A1 (en) 2000-08-03
ATE431421T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
DK0797676T3 (da) Rekombinant adenoviral vektor og fremgangsmåder til anvendelse deraf
DK0836648T3 (da) Rekombinant MVA-virus og anvendelse deraf
NO950939D0 (no) Defektive adenovirusvektorer og deres anvendelse i gene-terapien
DE69731611D1 (de) Eine Zusammensetzung enthaltend eine Detergenz und einen ein Tumorsuppressorgen kodierenden, adenoviralen Vektor
EP0710288A4 (de) Adenovirale vektoren für die behandlung der hämophilie
IS4762A (is) Samfallandi eitlaveiru genaferjukerfi og frumulínur
DK1151121T3 (da) Vektorer og virale vacciner baseret på rekombinante porcine adenovirus
EP0797436A4 (de) Neuartige adenovirale vektoren, verpackungsszellinien, rekombinante adenoviren und verfahren
DE69830251D1 (de) Langes pentraxin ptx3 enthaltende pharmazeutische zusammensetzungen
CY1109288T1 (el) Αδενοϊικοι φορεις οχηματα με απαλοιφη ε1β
HUP9802587A2 (hu) Glükózzal indukálható rekombináns virális vektor, ezt tartalmazó gyógyszerkészítmény és ezzel transzformált sejtek
EP1418948A4 (de) Replizierende adenovirus-vektoren
DK1071805T3 (da) Adenovirusvektorer til sygdomsbehandling
ATE397065T1 (de) Regulatorische konstrukte, die das intron 3 des prostat-spezifischen membranatigen-gens enthalten
WO2001021761A3 (es) Vectores adenovirales recombinantes y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar y cicatrices hipertroficas
DK1224310T3 (da) Fremstilling af rekombinante adenovira og adenovirale banker
WO2000029573A3 (en) Adenoviral vectors
WO2004033696A3 (fr) Vecteurs adenoviraux recombinants et leurs applications
WO2000022136A3 (en) Recombinant e1a deleted adenoviral vectors
UA70909C2 (uk) Рекомбінантний аденовірусний вектор, фармацевтична композиція, що його містить, та набір для зменшення проліферації пухлинних клітин
BR0009666A (pt) Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1
ADENOVIRUS REPLICATION COMPETENT ADENOVIRUS
MY157873A (en) Recombinant mva virus, and the use thereof
MY119381A (en) Recombinant mva virus, and the use thereof
MY134484A (en) Recombinant mva virus, and the use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition